IMKELDI
NDC 81927-201, imatinib oral, solution, from Shorla Oncology Inc.,.
- Product NDC
- 81927-201
- Status
- Listed
- Labeler
- Shorla Oncology Inc.,
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219097
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81927-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMATINIB MESYLATE80 mg/mL
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81927-201-01 | 81927020101 | 140 mL in 1 BOTTLE (81927-201-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/26658bb7-9ba1-a10e-e063-6394a90a172e
Use it
Look up 81927-201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81927-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81927-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.